Stocks
Cardinal Health Financial Statements (CAH) |
||||||||||
| Cardinal Healthsmart-lab.ru | % | 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 13.08.2020 | 16.08.2021 | 11.08.2022 | 15.08.2023 | 14.08.2024 | 01.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 152 922 | 162 467 | 181 364 | 205 012 | 226 827 | 224 500 | |||
| Operating Income, bln rub | 1 773 | 1 841 | 1 648 | 727.0 | 1 243 | 2 183 | ||||
| EBITDA, bln rub | ? | -2 617 | 1 310 | 126.0 | 1 441 | 1 978 | 2 572 | |||
| Net profit, bln rub | ? | -3 693 | 611.0 | -932.0 | 261.0 | 852.0 | 1 263 | |||
| OCF, bln rub | ? | 1 960 | 2 429 | 3 122 | 2 839 | 3 762 | 1 570 | |||
| CAPEX, bln rub | ? | 375.0 | 400.0 | 387.0 | 481.0 | 511.0 | 509.0 | |||
| FCF, bln rub | ? | 1 585 | 2 029 | 2 735 | 2 358 | 3 251 | 1 061 | |||
| Dividend payout, bln rub | 569.0 | 573.0 | 559.0 | 525.0 | 499.0 | 496.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 93.8% | 0.00% | 201.1% | 58.6% | 39.3% | ||||
| OPEX, bln rub | 5 096 | 4 984 | 4 881 | 5 119 | 5 000 | 5 182 | ||||
| Cost of production, bln rub | 146 054 | 155 689 | 174 819 | 198 123 | 219 413 | 217 060 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 238.0 | 180.0 | 149.0 | 93.0 | 51.0 | 73.0 | ||||
| Assets, bln rub | 40 766 | 44 453 | 43 878 | 43 417 | 45 121 | 43 059 | ||||
| Net Assets, bln rub | ? | 1 792 | 1 794 | -706.0 | -2 851 | -3 213 | -3 277 | |||
| Debt, bln rub | 6 775 | 6 236 | 5 315 | 4 701 | 5 092 | 5 164 | ||||
| Cash, bln rub | 2 771 | 3 407 | 4 717 | 4 043 | 5 133 | 2 867 | ||||
| Net debt, bln rub | 4 004 | 2 829 | 598.0 | 658.0 | -41.0 | 2 297 | ||||
| Ordinary share price, rub | 52.2 | 57.1 | 52.3 | 94.6 | 98.3 | 93.8 | ||||
| Number of ordinary shares, mln | 293.0 | 292.0 | 279.0 | 261.0 | 245.0 | 243.0 | ||||
| Market cap, bln rub | 15 292 | 16 670 | 14 583 | 24 683 | 24 088 | 22 791 | ||||
| EV, bln rub | ? | 19 296 | 19 499 | 15 181 | 25 341 | 24 047 | 25 088 | |||
| Book value, bln rub | -9 483 | -8 300 | -8 335 | -8 932 | -9 663 | -9 665 | ||||
| EPS, rub | ? | -12.6 | 2.09 | -3.34 | 1.00 | 3.48 | 5.20 | |||
| FCF/share, rub | 5.41 | 6.95 | 9.80 | 9.03 | 13.3 | 4.37 | ||||
| BV/share, rub | -32.4 | -28.4 | -29.9 | -34.2 | -39.4 | -39.8 | ||||
| EBITDA margin, % | ? | -1.71% | 0.81% | 0.07% | 0.70% | 0.87% | 1.15% | |||
| Net margin, % | ? | -2.41% | 0.38% | -0.51% | 0.13% | 0.38% | 0.56% | |||
| FCF yield, % | ? | 10.4% | 12.2% | 18.8% | 9.55% | 13.5% | 4.66% | |||
| ROE, % | ? | -206.1% | 34.1% | 132.0% | -9.15% | -26.5% | -38.5% | |||
| ROA, % | ? | -9.06% | 1.37% | -2.12% | 0.60% | 1.89% | 2.93% | |||
| P/E | ? | -4.14 | 27.3 | -15.6 | 94.6 | 28.3 | 18.0 | |||
| P/FCF | 9.65 | 8.22 | 5.33 | 10.5 | 7.41 | 21.5 | ||||
| P/S | ? | 0.10 | 0.10 | 0.08 | 0.12 | 0.11 | 0.10 | |||
| P/BV | ? | -1.61 | -2.01 | -1.75 | -2.76 | -2.49 | -2.36 | |||
| EV/EBITDA | ? | -7.37 | 14.9 | 120.5 | 17.6 | 12.2 | 9.75 | |||
| Debt/EBITDA | -1.53 | 2.16 | 4.75 | 0.46 | -0.02 | 0.89 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.25% | 0.25% | 0.21% | 0.23% | 0.23% | 0.23% | ||||
| Cardinal Health shareholders | ||||||||||
